Q4 2024 Stryker Corp Earnings Call Transcript
Key Points
- Stryker Corp (SYK) reported impressive organic sales growth exceeding 10% for both Q4 and the full year 2024.
- The company achieved a 16% growth in adjusted EPS for Q4 and 15% for the full year compared to 2023.
- Stryker Corp (SYK) successfully completed seven acquisitions in 2024, contributing to its strong financial performance.
- The company announced a strategic acquisition of Inari, expanding its presence in the fast-growing peripheral vascular market.
- Stryker Corp (SYK) continues to see strong demand for its Mako robotic-assisted surgery systems, with record installations in the US and worldwide.
- The Spinal Implants business faced challenges in meeting performance expectations, leading to its planned divestiture.
- Foreign currency fluctuations had a negative impact on sales and earnings, with a $0.05 unfavorable impact on Q4 EPS.
- The acquisition of Inari is expected to have a dilutive impact on adjusted operating margin and EPS in 2025.
- There is uncertainty regarding the impact of potential tariffs on manufacturing operations in Mexico.
- The integration of new acquisitions and the divestiture of the Spinal Implants business may pose operational challenges.
Welcome to the fourth quarter 2024 Stryker earnings call. My name is Luke, and I'll be your operator for today's call. (Operator Instructions) This conference call will be recorded for replay purposes. For your planning purposes, and given the amount of content we have to cover, in the event the call runs long, we plan to end the call no later than 6:00 PM EST.
Before we begin, I'd like to remind you that discussions during this conference call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed in the most recent filings with the SEC. Also, the discussions will include certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures can be found in today's press release that is an exhibit to Stryker's current report on Form 8-K filed today with the SEC.
I would now like to turn over the call to Mr. Kevin Lobo, Chair and Chief Executive Officer. You may proceed, sir.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
